Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the detailed record of transactions filed by Bumpus Namandje. Officer active across 1 company, notably Recursion Pharmaceuticals, INC.. In total, 5 filings have been logged. Split: 0 buy · 2 sells. Total volume traded: €13k. History available since 17 March 2025. The latest transaction was filed on 3 June 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
Bumpus Namandje has 4 filings in total. Across the 4 sampled recent filings, all relate to Recursion Pharmaceuticals, INC. on XNAS, where he is a Director, with 0 in buys and 13368 in sells, from 2025-03-19 to 2026-06-22. The modal transaction nature is Attribution.